Long-term anti-ischemic effects of angiotensin-converting enzyme inhibition in patients after myocardial infarction

Journal of the American College of Cardiology

Volumn 30, Issue 2, 1997, Pages 400-405

  Van Den Heuvel, Ad F M ^a   Van Gilst, Wiek H ^a   Van Veldhuisen, Dirk J ^a   De Vries, Rob J M ^a   Dunselman, Peter H J M ^b   Kingma, J Herre ^c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Ignatius Hospital   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC ACID DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; DOUBLE-BLIND METHOD; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030802372     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00183-6     Document Type: Article

References (34)

1. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 319:1988;80-86.
2. Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet. 337:1991;872-876.
3. Ray SG, Pye M, Oldroyd KG, et al. Early treatment with captopril after acute myocardial infarction. Br Heart J. 69:1993;215-222.
4. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 316:1987;1429-1435.
5. Yusuf S, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 340:1992;1173-1178.
6. Pfeffer M, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Eng J Med. 327:1992;669-677.
7. Gibbs JSR, Crean PA, Mockus L, Wright C, Sutton GC, Fox KM. The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina. Br Heart J. 62:1989;112-117.
8. Cleland JGF, Henderson E, McLenachan J, Findlay IN, Dargie HJ. Effect of captopril, an angiotensin converting enzyme inhibitor, in patients with angina pectoris and heart failure. J Am Coll Cardiol. 17:1991;733-739.
9. Van Gilst WH, Tio RA, van Wijngaarden J, de Graeff PA, Wesseling H. Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia. J Cardiovasc Pharmacol. 19:(Suppl 5):1992;S134-S139.
10. Farber NE, Gross GJ. Prostaglandin redirection by thromboxane synthetase inhibition attenuation of myocardial stunning in canine heart . Circulation. 81:(Suppl I):1990;I-369-I-380.
11. Powell JS, Rouge M, Muller RKM, Baumgartner HR. Cilazapril suppresses myointimal proliferation after vascular injury effects on growth factor induction and vascular smooth muscle cells . Basic Res Cardiol. 86:(Suppl I):1991;65-74.
12. Linz W, Wiener G, Scholkens BA. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts. J Mol Cell Cardiol. 24:1992;909-919.
13. Wiemer G, Scholkens BA, Becker RHA, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 18:1991;558-563.
14. Mancini GBJ, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with cronary artery disease (the TREND study). Circulation. 94:1996;258-265.
15. Kingma JH, van Gilst WH, Peels CH, et al. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction results from the Captopril and Thombolysis Study (CATS) . Eur Heart J. 15:1994;898-907.
16. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension. 23:1994;659-666.
17. Richer C, Fornes P, Vacher E, Bruneval P, Giudicelli JF. Trandolapril's protective effects in stroke-prone spontaneously hypertensive rats persist long after treatment withdrawal. Am J Cardiol. 73:1994;26C-35C.
18. Rijneke RD, Ascoop CA, Talmon JL. Clinical significance of upsloping ST segments in exercise electrocardiography. Circulation. 61:1980;671-678.
19. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on a 6 weeks mortality and ventricular function after acute myocardial infarction. Lancet. 343:1994;1115-1122.
20. A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 345:1995;669-685.
21. van Gilst WH, Kingma JH, Peels KH, Dambrink JHE, St. John Sutton M. Which patient benefits from early angiotensin converting enzye inhibition after myocardial infarction? J Am Coll Cardiol. 28:1996;114-121.
22. Zimmerman BG, Sybertz EJ, Wong PC. Interaction between sympathetic and renin-angiotensin system. J Hypertension. 2:1984;581-587.
23. 1 attenuates postischemic contractile dysfunction after brief coronary occlusion and reperfusion. Am Heart J. 118:1989;17-24.
24. Gelvan D, Saltman P, Powell SR. Cardiac reperfusion damage prevented by a nitroxide free radical. Proc Natl Acad Sci USA. 88:1991;4680-4684.
25. Søgaard P, Gøtzsche CO, Ravkilde J, Thygesen K. Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction. Circulation. 87:1993;1093-1099.
26. Dohi Y, Hahn AWA, Boulanger CM, Buhler FR, Luscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension. 19:1992;131-137.
27. Daly P, Mettauer B, Rouleau JL, Cousineau D, Burgess JH. Lack of reflex increase in myocardial sympathetic tone after captopril potential antianginal effect . Circulation. 71:1985;317-325.
28. Klein WW, Khurmi NS, Eber B, Dusleag J. Effects of benazepril and metoprolol OROS alone and in combination on myocardial ischemia in patients with chronic stable angina. J Am Coll Cardiol. 16:1990;948-956.
29. de Graeff PA, van Gilst WH. Role of angiotensin-converting enzyme inhibition in angina pectoris. J Cardiovasc Pharmacol. 19:(Suppl 4):1992;S30-S37.
30. Konstam MA, Rousseau MF, Kronenberg MW, et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation. 86:1992;431-438.
31. Jonsson JR, Frewin DB, Head RJ. The effect of captopril treatment and its withdrawal on the gene expression of the renin-angiotensin system. Blood Pressure. 3:1994;97-105.
32. Cambien F, Costerousse O, Tiret L, et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 90:1994;669-676.
33. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 116:1992;78-84.
34. Camici PG, Rosen SD. Does positron emission tomography contribute to the management of clinical cardiac problems? Eur Heart J. 17:1996;174-181.